DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

414.64 6.64 (1.63%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $414.64 1.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $408.68
Previous Close $408.00
Daily Range $401.17 - $415.50
52-Week Range $269.50 - $437.64
Market Cap $42.2B
P/E Ratio 137.84
Dividend (Yield) $0.00 (0.0%)
Volume 583,180
Average Daily Volume 884,711
Current FY EPS $8.01

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst Blog

Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog

US Stock Futures Signal Lower Start On Wall Street

Health Care Sector Update for 01/23/2015: REGN, ASPX, CELG

The 5 Biggest Biotech Stocks

Today's Momo Momentum Stock Is Regeneron Pharmaceuticals (REGN)

Alexion Pharmaceuticals Proves That Soliris Isn't Immune To Failure

Amgen Will Deliver In 2015

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog

See More REGN News...

REGN's Top Competitors

REGN $414.64 (1.63%)
Current stock: REGN
AMGN $156.37 (1.12%)
Current stock: AMGN
GILD $104.15 (1.66%)
Current stock: GILD
BIIB $353.25 (0.59%)
Current stock: BIIB